30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Downs Christopher

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Downs Christopher's trades of CNS Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-01
B Purchase
19,380 -3.4%
416.48
US$4,170,183 		19,380 -3.4% 416.48 US$4,170,183
2023-08-23 2023-08-22
B Purchase
14,621 +30.3%
24.77
US$420,135 		14,621 +30.3% 24.77 US$420,135
2023-04-18 2023-04-17
B Purchase
49,225 -20.1%
84.99
US$4,686,272 		49,225 -20.1% 84.99 US$4,686,272
2021-12-07 2021-12-06
B Purchase
5,000 +3.4%
0.94
US$4,702 		5,000 +3.4% 0.94 US$4,702
2021-11-22 2021-11-19
B Purchase
4,500 +3.2%
1.15
US$5,192 		4,500 +3.2% 1.15 US$5,192
2020-08-25 2020-08-24
B Purchase
142,000 +inf%
2.04
US$289,680 		142,000 +inf% 2.04 US$289,680